- Tytuł:
- A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
- Autorzy:
- Źródło:
- Cancer Immunology, Immunotherapy. March 2012 61(3):373-384
Czasopismo naukowe